MicroRNA‐181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN‐γ production

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|11|998-1007

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.11, 2015-11, pp. : 998-1007

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MPO is a potential biomarker of acute graft-versus-host disease

By Ge Bei   Ye Haige  

Biomarkers in Medicine, Vol. 7, Iss. 3, 2013-06 ,pp. : 391-393

Future Medicine

Access to resources Recommend Favorite

Severe Eosinophilia as a Manifestation of Acute Graft-versus-Host Disease

By  

Oncology, Vol. 75, Iss. 3-4, 2008-09 ,pp. : 134-136

Karger

Access to resources Recommend Favorite

Grading acute graft‐versus‐host disease: Time to reconsider

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 3, 2015-05 ,pp. : 252-254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential microRNA biomarkers for acute ischemic stroke

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1639-1647

Spandidos Publications

Access to resources Recommend Favorite

What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease?

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 2, 2018-02 ,pp. : 166-177

John Wiley & Sons Inc

Access to resources Recommend Favorite